A methionine aminopeptidase-2 (MetAP2) inhibitor may exhibit anti-proliferative and anti-invasive abilities in CCA cell lines through the c-Myc, MMP2, and MMP9 pathways [51]. The gene discussed is MYC; the disease is cholangiocarcinoma.